Patent holdings for IPC class C07J 63/00

Total number of patents in this class: 495

10-year publication summary

26
53
36
34
43
32
35
35
25
12
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Reata Pharmaceuticals, Inc.
121
38
Reata Pharmaceuticals Holdings, LLC
47
21
Sage Therapeutics, Inc.
350
17
ViiV Healthcare UK (no.5) Limited
84
13
Hetero Labs Limited
44
12
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
813
11
Bristol-myers Squibb Company
4848
9
Ardelyx, Inc.
113
9
Glaxosmithkline LLC
538
7
Glaxosmithkline Biologicals S.A.
1631
6
Adjuvance Technologies, Inc., AKA Adjuvance
22
6
Daiichi Sankyo Company, Limited
1852
6
Memorial Sloan-Kettering Cancer Center
1889
6
Pacific Arrow Limited
14
6
ViiV Healthcare UK (No. 4) Limited
22
6
ViiV Healthcare UK (No. 5) Limited
46
6
Glaxosmithkline Intellectual Property (no.2) Limited
282
5
The General Hospital Corporation
4679
5
Valtion Teknillinen Tutkimuskeskus
156
5
President and Fellows of Harvard College
5908
4
Other owners 297